Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Chondrosarcoma and IDH1[original query] |
|---|
| Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma. Brain tumor pathology 2012 Feb . Arai M, Nobusawa S, Ikota H, Takemura S, Nakazato Y |
| Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nature genetics 2013 Aug 45 (8): 923-6. Tarpey Patrick S, Behjati Sam, Cooke Susanna L, Van Loo Peter, Wedge David C, Pillay Nischalan, Marshall John, O'Meara Sarah, Davies Helen, Nik-Zainal Serena, Beare David, Butler Adam, Gamble John, Hardy Claire, Hinton Jonathon, Jia Ming Ming, Jayakumar Alagu, Jones David, Latimer Calli, Maddison Mark, Martin Sancha, McLaren Stuart, Menzies Andrew, Mudie Laura, Raine Keiran, Teague Jon W, Tubio Jose M C, Halai Dina, Tirabosco Roberto, Amary Fernanda, Campbell Peter J, Stratton Michael R, Flanagan Adrienne M, Futreal P Andr |
| Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations. The American journal of surgical pathology 2013 Jun 37 (6): 787-95. Kerr Darcy A, Lopez Hector U, Deshpande Vikram, Hornicek Francis J, Duan Zhenfeng, Zhang Yaxia, Rosenberg Andrew E, Borger Darrel R, Nielsen G Pet |
| IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas. Clinical sarcoma research 2017 7 8. Cleven Arjen H G, Suijker Johnny, Agrogiannis Georgios, Briaire-de Bruijn Inge H, Frizzell Norma, Hoekstra Attje S, Wijers-Koster Pauline M, Cleton-Jansen Anne-Marie, Bovée Judith V M |
| IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma. Journal of Cancer 2018 9 (6): 998-1005. Lugowska Iwona, Teterycz Pawel, Mikula Michal, Kulecka Maria, Kluska Anna, Balabas Aneta, Piatkowska Magdalena, Wagrodzki Michal, Pienkowski Andrzej, Rutkowski Piotr, Ostrowski Jer |
| Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Oct . Zhu Guo Gord, Nafa Khedoudja, Agaram Narasimhan, Zehir Ahmet, Benayed Ryma, Sadowska Justyna, Borsu Laetitia, Kelly Ciara, Tap William D, Fabbri Nicola, Athanasian Edward, Boland Patrick J, Healey John H, Berger Michael F, Ladanyi Marc, Hameed Mee |
| Characterisation of isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 gene mutation and the d-2-hydroxyglutarate oncometabolite level in dedifferentiated chondrosarcoma. Histopathology 2019 10 76 (5): 722-730. Mohammad Nissreen, Wong Derek, Lum Amy, Lin Jonah, Ho Julie, Lee Cheng-Han, Yip Steph |
| Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma. The American journal of surgical pathology 2020 11 45 (6): 812-819. Joseph Nancy M, McGill Kevin C, Horvai Andrew |
| Prognostic impact of IDH mutations in chondrosarcoma. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2021 Sep . Nakagawa Makoto, Sekimizu Masaya, Endo Makoto, Kobayashi Eisuke, Iwata Shintaro, Fukushima Suguru, Yoshida Akihiko, Kitabayashi Issay, Ichikawa Hitoshi, Kawai Akira, Nakatani Fumihi |
| Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma. Cells 2021 8 10 (8): . Murnyak Balazs, Huang L Er |
| Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes. Cancer & metabolism 2021 3 9 (1): 13. Pathmanapan Sinthu, Ilkayeva Olga, Martin John T, Loe Adrian Kwan Ho, Zhang Hongyuan, Zhang Guo-Fang, Newgard Christopher B, Wunder Jay S, Alman Benjamin |
| A genetic model for central chondrosarcoma evolution correlates with patient outcome. Genome medicine 2022 8 14 (1): 99. Cross William, Lyskjær Iben, Lesluyes Tom, Hargreaves Steven, Strobl Anna-Christina, Davies Christopher, Waise Sara, Hames-Fathi Shadi, Oukrif Dahmane, Ye Hongtao, Amary Fernanda, Tirabosco Roberto, Gerrand Craig, Baker Toby, Barnes David, Steele Christopher, Alexandrov Ludmil, Bond Gareth, , Cool Paul, Pillay Nischalan, Van Loo Peter, Flanagan Adrienne |
| Periosteal chondrosarcoma: A case series in a referral center with survivorship analysis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022 6 48 (8): 1730-1738. Pacheco Marina, Barra Lucia, Gambarotti Marco, Magagnoli Giovanna, Sbaraglia Marta, Asioli Sofia, Cocchi Stefania, Carretta Elisa, Frisoni Tommaso, Benini Stefania, Dei Tos Angelo Paolo, Righi Alber |
| Plk1 regulates mutant IDH1 enzyme activity and mutant IDH2 ubiquitination in mitosis. Cellular signalling 2022 2 92 110279. Saikiran Reddy M, Bhattacharjee Debanjan, Jain Nisha |
| Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients. Medeniyet medical journal 2023 6 38 (2): 102-110. Emre Leventoglu, Gurses Sahin, Sule Yesil, Ceyhun Bozkurt, Nazmiye Yuksek, Ali Fettah, Sule Toprak, Burcak Kurucu Bilgin, Emre Capkinoglu, Nilgun Eroglu, Sibel Akpinar Tekgunduz, Ayse Ulya Ert |
| Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma. Cancer research communications 2023 3 3 (3): 431-443. Dermawan Josephine Kam Tai, Nafa Khedoujia, Mohanty Abhinita, Xu Yingjuan, Rijo Ivelise, Casanova Jacklyn, Villafania Liliana, Benhamida Jamal, Kelly Ciara M, Tap William D, Boland Patrick J, Fabbri Nicola, Healey John H, Ladanyi Marc, Lu Chao, Hameed Mee |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: